Variant report
Variant | nsv9256 |
---|---|
Chromosome Location | chr15:45117926-45119121 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:8)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:8 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BHLHE40 | chr15:45118895-45119140 | HepG2 | liver: | n/a | n/a |
2 | FOSL2 | chr15:45118895-45119133 | HepG2 | liver: | n/a | n/a |
3 | FOSL2 | chr15:45117823-45118083 | HepG2 | liver: | n/a | chr15:45117938-45117950 chr15:45117936-45117947 chr15:45117940-45117948 chr15:45117938-45117945 |
4 | FOXA1 | chr15:45118515-45118872 | HepG2 | liver: | n/a | chr15:45118744-45118756 chr15:45118654-45118666 chr15:45118658-45118670 |
5 | MYC | chr15:45118856-45119058 | HUVEC | blood vessel: | n/a | n/a |
6 | POLR2A | chr15:45118719-45118862 | HUVEC | blood vessel: | n/a | n/a |
7 | POLR2A | chr15:45118925-45118963 | HUVEC | blood vessel: | n/a | n/a |
8 | RXRA | chr15:45118485-45118724 | HepG2 | liver: | n/a | n/a |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-TRIM69-1 | chr15:45119097-45119292 | ENSG00000259187.1 |
2 | lnc-TRIM69-1 | chr15:45118738-45118965 | ENSG00000259187.1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000259187 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs371149753 | chr15:45117973-45117974 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs201755799 | chr15:45118037-45118038 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs200285507 | chr15:45118039-45118040 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs201222316 | chr15:45118075-45118076 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs28526450 | chr15:45118134-45118135 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs151176319 | chr15:45118151-45118152 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs193022620 | chr15:45118162-45118163 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs141209575 | chr15:45118164-45118165 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs201427758 | chr15:45118167-45118168 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs199710364 | chr15:45118169-45118170 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs2470926 | chr15:45118261-45118262 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs537341272 | chr15:45118359-45118360 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs550600085 | chr15:45118362-45118363 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs184935428 | chr15:45118413-45118414 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs201608646 | chr15:45118444-45118445 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs79232366 | chr15:45118482-45118483 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs9020 | chr15:45118490-45118491 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs368260928 | chr15:45118495-45118496 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs536370881 | chr15:45118500-45118501 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs553016806 | chr15:45118534-45118535 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs199594326 | chr15:45118545-45118546 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs113520434 | chr15:45118625-45118626 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs112299533 | chr15:45118629-45118630 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs200686122 | chr15:45118645-45118646 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs202031595 | chr15:45118688-45118689 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs200168863 | chr15:45118700-45118701 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs112514204 | chr15:45118757-45118758 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs200438293 | chr15:45118772-45118773 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs1669847 | chr15:45118908-45118909 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs572962822 | chr15:45118986-45118987 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs538779495 | chr15:45119084-45119085 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs558473168 | chr15:45119114-45119115 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs5001468 | chr15:45119121-45119122 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Schizophrenia | 19415332 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
cataract | 16735990 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 21979893 | CNVD |
spastic paraplegia with thinning of corpus callosum | 19105190 | CNVD |
Schizophrenia | 21324950 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Disease | 21824424 | CNVD |
Melanoma | 18172304 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Gastric cancer | 17167181 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Intellectual disability | 22102821 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21785460 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Cancer | 21129771 | CNVD |
Papillary thyroid carcinoma | 22161024 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 21045282 | CNVD |
Breast cancer | 22032731 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Cancer | 16751803 | CNVD |
Melanoma | 17363583 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Marfan syndrome | 17492313 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr15:45105800-45121600 | Weak transcription | Fetal Intestine Small | intestine |
2 | chr15:45112000-45123000 | Weak transcription | Esophagus | oesophagus |
3 | chr15:45112600-45120400 | Weak transcription | Lung | lung |
4 | chr15:45113400-45119600 | Weak transcription | Stomach Mucosa | stomach |
5 | chr15:45117200-45120400 | Enhancers | HepG2 | liver |
6 | chr15:45117400-45120400 | Weak transcription | Gastric | stomach |
7 | chr15:45117600-45119000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
8 | chr15:45117600-45119000 | Weak transcription | Liver | Liver |
9 | chr15:45117600-45120400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
10 | chr15:45117600-45121800 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
11 | chr15:45117800-45118200 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
12 | chr15:45118200-45118400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
13 | chr15:45118400-45118600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
14 | chr15:45118400-45123000 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
15 | chr15:45118600-45120400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
16 | chr15:45119000-45119200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
17 | chr15:45119000-45119400 | Enhancers | Liver | Liver |